Acadian Asset Management
TIL icon

Acadian Asset Management’s Instil Bio TIL Stock Holding History

Acadian Asset Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,490
Closed -$233K – 1832
2025
Q1 		$233K Buy
+13,490
New +$280K ﹤0.01% 1231
2024
Q3 		– Sell
-10,244
Closed -$104K – 2336
2024
Q2 		$104K Hold
10,244
– – ﹤0.01% 1533
2024
Q1 		$109K Sell
10,244
-3,770
-27% -$41.3K ﹤0.01% 1275
2023
Q4 		$106K Sell
14,014
-11,199
-44% -$81K ﹤0.01% 1349
2023
Q3 		$214K Buy
25,213
+6,192
+33% +$62.4K ﹤0.01% 1182
2023
Q2 		$208K Buy
19,021
+15,444
+432% +$189K ﹤0.01% 1265
2023
Q1 		$47K Sell
3,577
-19,251
-84% -$285K ﹤0.01% 1520
2022
Q4 		$287K Buy
+22,828
New +$1.13M ﹤0.01% 1197

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Acadian Asset Management's TIL Position: Q2 2025 in Review

Acadian Asset Management sold out of Instil Bio (TIL) in Q2 2025, closing a stake of 13,490 shares — an estimated $233K sold.

Acadian Asset Management first reported a position in TIL in Q4 2022 and held it in 8 quarters. The position peaked at $287K in Q4 2022. 38 funds tracked by Wall St. Rank hold TIL as of Q2 2025.

  • Acadian Asset Management reported no remaining Instil Bio position as of Q2 2025 after selling out during the quarter.
  • Acadian Asset Management sold 13,490 Instil Bio shares in Q2 2025, an estimated $233K.
  • Acadian Asset Management first reported a position in Instil Bio in Q4 2022 and held it in 8 quarters.
  • Acadian Asset Management's Instil Bio position peaked at $287K in Q4 2022.
  • 38 funds tracked by Wall St. Rank held Instil Bio as of Q2 2025.

Based on Acadian Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.